Author:
Hayashi Tsuyoshi,Murakami Kosuke,Ando Hirokazu,Ueno Sayuri,Kobayashi Sakura,Muramatsu Masamichi,Tanikawa Takashi,Kitamura Masashi
Abstract
AbstractHuman norovirus (HuNoV) is a major cause of acute gastroenteritis and foodborne diseases worldwide with public health concern, yet no antiviral therapies have been developed. In this study, we aimed to screen crude drugs, which are components of Japanese traditional medicine, ‘‘Kampo” to see their effects on HuNoV infection using a reproducible HuNoV cultivation system, stem-cell derived human intestinal organoids/enteroids (HIOs). Among the 23 crude drugs tested, Ephedra herba significantly inhibited HuNoV infection in HIOs. A time-of-drug addition experiment indicated that this crude drug likely targets post-entry step for the inhibition. To our knowledge, this is the first anti-HuNoV inhibitor screen targeting crude drugs, and Ephedra herba was identified as a novel inhibitor candidate that merits further study.
Publisher
Cold Spring Harbor Laboratory